The Chemical Data

OQ Chemicals Launches Biomass-Balanced Ox Balance Neopentyl Glycol Di heptanoate for Cosmetics

Global chemical company OQ Chemicals is launching OxBalance neopentyl glycol diheptanoate (NPG diheptanoate), a lightweight, biomass-balanced emollient ester designed for use in cosmetics. Certified under the International Sustainability and Carbon Certification (ISCC) PLUS standard, OxBalance NPG diheptanoate offers a sustainable…

Read MoreOQ Chemicals Launches Biomass-Balanced Ox Balance Neopentyl Glycol Di heptanoate for Cosmetics

CF Industries and POET Partner to Showcase Low-Carbon Fertilizer for Reducing Ethanol’s Carbon Intensity in Corn Production

CF Industries Holdings, Inc. (NYSE: CF), a global leader in hydrogen and nitrogen products and the largest producer of ammonia worldwide, has partnered with POET LLC, the largest biofuel producer globally and a leader in sustainable bioproducts. Together, they announced…

Read MoreCF Industries and POET Partner to Showcase Low-Carbon Fertilizer for Reducing Ethanol’s Carbon Intensity in Corn Production

Integrated DNA Technologies and SeQure Dx Enter Licensing Agreement to Enhance CRISPR-Based Therapeutics

Integrated DNA Technologies (IDT), a global leader in CRISPR genome editing solutions, has entered into a licensing agreement with SeQure Dx, a company specializing in off-target analysis for gene modification customers. This agreement enhances IDT’s CRISPR portfolio, offering comprehensive solutions…

Read MoreIntegrated DNA Technologies and SeQure Dx Enter Licensing Agreement to Enhance CRISPR-Based Therapeutics

Toray Honored with Prestigious WIPO Award for Breakthrough in Reverse Osmosis Membrane Technology

Toray Industries, Inc. announced today that it has been honored with the 2024 National Commendation for Invention Award’s WIPO Award by the Japan Institute of Invention and Innovation. This recognition is for the creation of a robust reverse osmosis (RO)…

Read MoreToray Honored with Prestigious WIPO Award for Breakthrough in Reverse Osmosis Membrane Technology

AskBio’s AB-1005 GDNF Gene Therapy for Parkinson’s Receives FDA Fast Track, MHRA Innovation Passport

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company fully owned by Bayer AG, announced today that the FDA has granted Fast Track Designation for AB-1005, intended for moderate Parkinson’s disease. AB-1005 has also received the Innovation Passport…

Read MoreAskBio’s AB-1005 GDNF Gene Therapy for Parkinson’s Receives FDA Fast Track, MHRA Innovation Passport